In Qian’s experiment, mangiferin improved inflammation in the DHEA-induced PCOS rat model by reducing the pp65/p65 ratio and blocking NF-κB signaling and the expression of the inflammatory cytokines IL-6, IL-1β, and TNF-α. Here, IL1B is linked to polycystic ovary syndrome.